Horien Biochemical Technology Co (ROCO:7814) Scaled Net Operating Assets: 0.27 (As of Dec. 2025)


ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
21 GF Score
Price NT$36.15
! 5 Warning Signs
View Full Analysis

What is Horien Biochemical Technology Co Scaled Net Operating Assets?

Horien Biochemical Technology Co ROCO:7814 21 Scaled Net Operating Assets is 0.27 as of Dec. 2025. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Horien Biochemical Technology Co's operating assets for the quarter that ended in Dec. 2025 was NT$110.66 Mil. Horien Biochemical Technology Co's operating liabilities for the quarter that ended in Dec. 2025 was NT$24.51 Mil. Horien Biochemical Technology Co's Total Assets for the quarter that ended in Sep. 2025 was NT$317.34 Mil. Therefore, Horien Biochemical Technology Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.27.

Horien Biochemical Technology Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co Scaled Net Operating Assets Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
0.35 0.39 0.33 0.26

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Scaled Net Operating Assets Get a 7-Day Free Trial 0.00 0.00 0.23 0.27 0.27

ROCO:7814 vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Horien Biochemical Technology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Horien Biochemical Technology Co Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Horien Biochemical Technology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Horien Biochemical Technology Co's Scaled Net Operating Assets falls into.


ROCO:7814
21GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Horien Biochemical Technology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(110.66-24.507)/330.148
=0.26

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=320.253 - 209.593
=110.66

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=26.146 - 0.07 - 1.569
=24.507

Horien Biochemical Technology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Sep. 2025 )
=(110.66-24.507)/317.337
=0.27

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=320.253 - 209.593
=110.66

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=26.146 - 0.07 - 1.569
=24.507

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.27 mean?
Horien Biochemical Technology Co (ROCO:7814) has a Scaled Net Operating Assets of 0.27 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Horien Biochemical Technology Co and its competitors.
Is Horien Biochemical Technology Co's Scaled Net Operating Assets too high?
Horien Biochemical Technology Co's current Scaled Net Operating Assets is 0.27. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Scaled Net Operating Assets compare to VRTX and REGN?
Horien Biochemical Technology Co's Scaled Net Operating Assets of 0.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Horien Biochemical Technology Co and its competitors. Horien Biochemical Technology Co's current Scaled Net Operating Assets is 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Scaled Net Operating Assets of 0.27. The current Scaled Net Operating Assets is 0.27. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Scaled Net Operating Assets is 0.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score

Get the complete analysis for ROCO:7814

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$36.15
Price